629 related articles for article (PubMed ID: 33259822)
1. Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid.
Ogiso T; Fukami T; Zhongzhe C; Konishi K; Nakano M; Nakajima M
Toxicology; 2021 Jan; 448():152648. PubMed ID: 33259822
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450-mediated bioactivation of mefenamic acid to quinoneimine intermediates and inactivation by human glutathione S-transferases.
Venkataraman H; den Braver MW; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2014 Dec; 27(12):2071-81. PubMed ID: 25372302
[TBL] [Abstract][Full Text] [Related]
3. Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid.
Vredenburg G; Elias NS; Venkataraman H; Hendriks DF; Vermeulen NP; Commandeur JN; Vos JC
Chem Res Toxicol; 2014 Apr; 27(4):576-86. PubMed ID: 24552538
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the acyl-adenylate linked metabolite of mefenamic Acid.
Horng H; Benet LZ
Chem Res Toxicol; 2013 Mar; 26(3):465-76. PubMed ID: 23402341
[TBL] [Abstract][Full Text] [Related]
5. The nonenzymatic reactivity of the acyl-linked metabolites of mefenamic acid toward amino and thiol functional group bionucleophiles.
Horng H; Benet LZ
Drug Metab Dispos; 2013 Nov; 41(11):1923-33. PubMed ID: 23975029
[TBL] [Abstract][Full Text] [Related]
6. Effect of human glutathione S-transferases on glutathione-dependent inactivation of cytochrome P450-dependent reactive intermediates of diclofenac.
Dragovic S; Boerma JS; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2013 Nov; 26(11):1632-41. PubMed ID: 24083800
[TBL] [Abstract][Full Text] [Related]
7. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
Powis G; See KL; Santone KS; Melder DC; Hodnett EM
Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
[TBL] [Abstract][Full Text] [Related]
8. Formation of a Toxic Quinoneimine Metabolite from Diclofenac: A Quantum Chemical Study.
Ramesh M; Bharatam PV
Drug Metab Lett; 2019; 13(1):64-76. PubMed ID: 30210009
[TBL] [Abstract][Full Text] [Related]
9. Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation.
Hata T; Kawai S; Okamura H; Nishida T
Biodegradation; 2010 Sep; 21(5):681-9. PubMed ID: 20127144
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs) by Streptomyces griseolus CYP105A1 and its variants.
Yogo Y; Yasuda K; Takita T; Yasukawa K; Iwai Y; Nishikawa M; Sugimoto H; Ikushiro S; Sakaki T
Drug Metab Pharmacokinet; 2022 Aug; 45():100455. PubMed ID: 35617891
[TBL] [Abstract][Full Text] [Related]
11. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
[TBL] [Abstract][Full Text] [Related]
12. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.
Taguchi K; Konishi T; Nishikawa H; Kitamura S
Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of mefenamic acid leading to mefenamyl-S-acyl-glutathione adduct formation in vitro and in vivo in rat.
Grillo MP; Tadano Lohr M; Wait JC
Drug Metab Dispos; 2012 Aug; 40(8):1515-26. PubMed ID: 22577085
[TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
Gaganis P; Miners JO; Knights KM
Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
[TBL] [Abstract][Full Text] [Related]
15. Human glutathione S-transferases- and NAD(P)H:quinone oxidoreductase 1-catalyzed inactivation of reactive quinoneimines of amodiaquine and N-desethylamodiaquine: Possible implications for susceptibility to amodiaquine-induced liver toxicity.
Zhang Y; den Braver-Sewradj SP; Vos JC; Vermeulen NPE; Commandeur JNM
Toxicol Lett; 2017 Jun; 275():83-91. PubMed ID: 28478157
[TBL] [Abstract][Full Text] [Related]
16. The mechanisms of potentiation and inhibition of GABA
Rossokhin AV; Sharonova IN; Dvorzhak A; Bukanova JV; Skrebitsky VG
Neuropharmacology; 2019 Dec; 160():107795. PubMed ID: 31560908
[TBL] [Abstract][Full Text] [Related]
17. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
18. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid.
Khansari PS; Halliwell RF
Neurochem Int; 2009 Dec; 55(7):683-8. PubMed ID: 19563851
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes.
Mano Y; Usui T; Kamimura H
Eur J Clin Pharmacol; 2007 Feb; 63(2):211-6. PubMed ID: 17200831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
